www.newsmax.com
Congress Calls on Novo Nordisk to Lower Drug Prices
The boss of the Danish pharmaceutical giant behind the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy promised Tuesday to examine lowering their prices in the United States, after coming under pressure from Congress.The stakes are high for U.S. patients, some...